Literature DB >> 27780825

Transglutaminase Interaction with α6/β4-Integrin Stimulates YAP1-Dependent ΔNp63α Stabilization and Leads to Enhanced Cancer Stem Cell Survival and Tumor Formation.

Matthew L Fisher1, Candace Kerr1, Gautam Adhikary1, Dan Grun1, Wen Xu1, Jeffrey W Keillor2, Richard L Eckert3,4,5,6.   

Abstract

Transglutaminase 2 (TG2) expression is required for epidermal squamous cell carcinoma cancer stem cell survival. However, the molecular signaling mechanisms triggered by TG2 that mediate this survival action are not well understood. Here we show that TG2 is constitutively expressed in ECS cells, where it interacts with α6/β4 integrin to stimulate FAK and Src signaling, leading to PI3K activation of phosphoinositide-dependent kinase 1 (PDK1). PDK1 inhibits Hippo signaling, leading to enhanced nuclear accumulation of YAP1, which interacted with and stabilized ΔNp63α to enhance epidermal squamous cell carcinoma spheroid formation, invasion, and migration. Overall, these findings suggest that constitutive TG2 expression results in stabilization of ΔNp63α, leading to maintenance of cancer stem cell properties and enhanced tumor formation. Cancer Res; 76(24); 7265-76. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27780825      PMCID: PMC5161627          DOI: 10.1158/0008-5472.CAN-16-2032

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

Review 1.  The role of p63 in development and differentiation of the epidermis.

Authors:  Maranke I Koster; Dennis R Roop
Journal:  J Dermatol Sci       Date:  2004-02       Impact factor: 4.563

Review 2.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

3.  Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.

Authors:  Matthew L Fisher; Jeffrey W Keillor; Wen Xu; Richard L Eckert; Candace Kerr
Journal:  Mol Cancer Res       Date:  2015-05-01       Impact factor: 5.852

4.  Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin.

Authors:  Haiying Zhang; H Amalia Pasolli; Elaine Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

5.  Survival of skin cancer stem cells requires the Ezh2 polycomb group protein.

Authors:  Gautam Adhikary; Daniel Grun; Sivaprakasam Balasubramanian; Candace Kerr; Jennifer M Huang; Richard L Eckert
Journal:  Carcinogenesis       Date:  2015-05-12       Impact factor: 4.944

Review 6.  The Hippo signaling pathway and stem cell biology.

Authors:  Azucena Ramos; Fernando D Camargo
Journal:  Trends Cell Biol       Date:  2012-05-31       Impact factor: 20.808

7.  Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1.

Authors:  Run Fan; Nam-Gyun Kim; Barry M Gumbiner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

8.  Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer.

Authors:  Bakhtiyor Yakubov; Bhadrani Chelladurai; Jordan Schmitt; Robert Emerson; John J Turchi; Daniela Matei
Journal:  Neoplasia       Date:  2013-06       Impact factor: 5.715

9.  Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas.

Authors:  J G Rheinwald; M A Beckett
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

10.  Small molecule inhibitors target the tissue transglutaminase and fibronectin interaction.

Authors:  Bakhtiyor Yakubov; Lan Chen; Alexey M Belkin; Sheng Zhang; Bhadrani Chelladurai; Zhong-Yin Zhang; Daniela Matei
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

View more
  27 in total

1.  ΔNp63α exerts antitumor functions in cervical squamous cell carcinoma.

Authors:  Ying Zhou; Hanyuan Liu; Juan Wang; Xiaolin Wang; Lili Qian; Fei Xu; Weiguo Song; Dabao Wu; Zhen Shen; Dingqing Feng; Bin Ling; Weihua Xiao; Ge Shan; Liang Chen
Journal:  Oncogene       Date:  2019-10-01       Impact factor: 9.867

2.  Transglutaminase 2 Is a Direct Target Gene of YAP-TAZ-Response.

Authors:  Matthew L Fisher; Gautam Adhikary; Candace Kerr; Daniel Grun; Richard L Eckert
Journal:  Cancer Res       Date:  2017-08-15       Impact factor: 12.701

3.  Combination cisplatin and sulforaphane treatment reduces proliferation, invasion, and tumor formation in epidermal squamous cell carcinoma.

Authors:  Candace Kerr; Gautam Adhikary; Daniel Grun; Nicholas George; Richard L Eckert
Journal:  Mol Carcinog       Date:  2017-08-28       Impact factor: 4.784

4.  Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity.

Authors:  Ellen A Rorke; Gautam Adhikary; Henryk Szmacinski; Joseph R Lakowicz; David J Weber; Raquel Godoy-Ruiz; Purushottamachar Puranik; Jeffrey W Keillor; Eric W J Gates; Richard L Eckert
Journal:  Mol Carcinog       Date:  2021-10-05       Impact factor: 4.784

5.  NRP-1 interacts with GIPC1 and α6/β4-integrins to increase YAP1/∆Np63α-dependent epidermal cancer stem cell survival.

Authors:  Daniel Grun; Gautam Adhikary; Richard L Eckert
Journal:  Oncogene       Date:  2018-05-14       Impact factor: 9.867

6.  NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival.

Authors:  Daniel Grun; Gautam Adhikary; Richard L Eckert
Journal:  Mol Carcinog       Date:  2018-12-21       Impact factor: 4.784

7.  Structure-Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase.

Authors:  Abdullah Akbar; Nicole M R McNeil; Marie R Albert; Viviane Ta; Gautam Adhikary; Karine Bourgeois; Richard L Eckert; Jeffrey W Keillor
Journal:  J Med Chem       Date:  2017-09-14       Impact factor: 7.446

Review 8.  p63-related signaling at a glance.

Authors:  Matthew L Fisher; Seamus Balinth; Alea A Mills
Journal:  J Cell Sci       Date:  2020-09-11       Impact factor: 5.285

Review 9.  p53 shades of Hippo.

Authors:  Noa Furth; Yael Aylon; Moshe Oren
Journal:  Cell Death Differ       Date:  2017-10-06       Impact factor: 15.828

10.  Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53.

Authors:  Patrizia Malkomes; Ilaria Lunger; Elsie Oppermann; Khalil Abou-El-Ardat; Thomas Oellerich; Stefan Günther; Can Canbulat; Sabrina Bothur; Frank Schnütgen; Weijia Yu; Susanne Wingert; Nadine Haetscher; Claudia Catapano; Marina S Dietz; Mike Heilemann; Hans-Michael Kvasnicka; Katharina Holzer; Hubert Serve; Wolf Otto Bechstein; Michael A Rieger
Journal:  Oncogene       Date:  2021-06-08       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.